RIZZELLO, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 219
EU - Europa 140
AS - Asia 52
AF - Africa 2
SA - Sud America 1
Totale 414
Nazione #
US - Stati Uniti d'America 212
IT - Italia 44
CN - Cina 31
FR - Francia 25
DE - Germania 16
GB - Regno Unito 14
IE - Irlanda 11
JP - Giappone 10
CA - Canada 7
BG - Bulgaria 6
UA - Ucraina 5
CZ - Repubblica Ceca 4
FI - Finlandia 4
IN - India 4
HK - Hong Kong 3
NL - Olanda 3
BE - Belgio 2
ES - Italia 2
KR - Corea 2
SE - Svezia 2
AR - Argentina 1
CH - Svizzera 1
IL - Israele 1
RU - Federazione Russa 1
TN - Tunisia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 414
Città #
Columbus 19
Ann Arbor 13
Fairfield 13
Santa Cruz 12
Ashburn 10
Chandler 9
Bologna 8
Dublin 8
Houston 8
Milan 8
Buffalo 7
Chicago 7
Fabriano 7
Shanghai 6
Sofia 6
Bremen 5
New York 5
Seattle 5
Woodbridge 5
Boardman 4
Hamburg 4
Mountain View 4
Wilmington 4
Wuhan 4
Beijing 3
Bengaluru 3
Brookline 3
Cambridge 3
Cardiff 3
Helsinki 3
Los Angeles 3
San Diego 3
Amsterdam 2
Austin 2
Bellaria-Igea Marina 2
Boston 2
Brussels 2
Burnaby 2
Florissant 2
Frankfurt am Main 2
Montreal 2
Rimini 2
San Francisco 2
Seoul 2
Southend 2
Stockholm 2
Umeda 2
Athens 1
Auburn 1
Ballyclare 1
Bonn 1
Boulder 1
Brno 1
Calgary 1
Catanzaro 1
Charlotte 1
Clinton 1
Council Bluffs 1
Enfield 1
Evanston 1
Gennep 1
Genoa 1
Guangzhou 1
Gubbio 1
Gurgaon 1
Hangzhou 1
Herndon 1
Hong Kong 1
Hyattsville 1
Ichibacho 1
Lappeenranta 1
Leesburg 1
Liverpool 1
London 1
Loreggia 1
Madison 1
Maisse 1
Man Kok 1
Misano Adriatico 1
Modena 1
Morioka 1
Muizenberg 1
Naples 1
New Orleans 1
Nuremberg 1
Ottawa 1
Oxford 1
Pacifica 1
Pamplona 1
Paris 1
Pilar 1
Quanzhou 1
Reston 1
Rishon LeTsiyyon 1
Rozzano 1
Sacramento 1
San Jose 1
San Mateo 1
Scranton 1
Siena 1
Totale 288
Nome #
Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma, file e1dcb336-5551-7715-e053-1705fe0a6cc9 185
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma, file e1dcb339-d8d7-7715-e053-1705fe0a6cc9 72
Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents, file e1dcb32f-2aa3-7715-e053-1705fe0a6cc9 65
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients, file c98b8a6c-52ea-40eb-9081-4d2f4d2811aa 26
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma, file e1dcb339-aac2-7715-e053-1705fe0a6cc9 20
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases, file 11e3ddaf-42a3-45f5-9568-708677b17117 17
Role of serum-free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma, file eace3be2-8518-47e0-be44-569952f6bb37 15
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials, file 1071f612-5177-43ab-a363-861587d0ab2c 7
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma, file 30987cd1-61c8-42b7-8afd-bd6ca7056083 6
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials, file d683cc65-edf1-4f8c-9350-ac021cbdfd06 4
Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight, file 4017cb2b-fbeb-43cb-bf5c-ddac73c50b03 3
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients, file 5a68eabb-9fdf-4fdc-8442-b66c0cb5ced4 1
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma, file 7f0eb466-1a69-420a-829b-c3a81e43fa5b 1
Totale 422
Categoria #
all - tutte 1.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.516


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 0 0 0 2 1
2020/202127 3 0 2 1 0 2 1 5 3 4 2 4
2021/2022107 6 4 3 19 11 6 11 2 4 9 26 6
2022/2023122 5 16 13 19 8 9 6 8 11 2 17 8
2023/2024163 1 10 8 21 14 27 10 23 12 10 27 0
Totale 422